Head and Neck Cutaneous Carcinoma — Trials

Head and Neck Cutaneous Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

55 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 23
Recruiting: 13
Ph III recruiting: 2
Growth YoY: —
Industry share: 0%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05110781	Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site	terminated	Phase 2	1	University of California, DavisOTHER	1	Jun 5, 2026	clinicaltrials
NCT04242173	Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC	terminated	Phase 2	3	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Nov 4, 2022